These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4002202)

  • 1. Turnover of fibrinopeptide A (FPA) in rabbits.
    Ariga T; Oshiba S; Akashi Y; Endoh E; Imai H; Sawai H
    Thromb Res; 1985 Apr; 38(2):137-47. PubMed ID: 4002202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition of human fibrinopeptide A in normal and nephrectomized rabbits.
    Harenberg J; Stehle G; Waibel S; Hermann HJ; Eisenhut M; Zimmermann R
    Thromb Res; 1983 Oct; 32(1):1-13. PubMed ID: 6658706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between fibrinopeptide a (FPA) level and fibrinogen kinetics in patients with malignant disease.
    Yoda Y; Nakamura H; Abe T
    Bibl Haematol; 1983; (49):163-72. PubMed ID: 6667244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 125I-fibrinogen kinetics and fibrinopeptide A in patients with disseminated neoplasias.
    Mombelli G; Roux A; Haeberli A; Straub PW
    Blood; 1982 Aug; 60(2):381-8. PubMed ID: 7093524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activity.
    Nossel HL; Ti M; Kaplan KL; Spanondis K; Soland T; Butler VP
    J Clin Invest; 1976 Nov; 58(5):1136-44. PubMed ID: 993337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic characterization of a saturable pathway for rapid clearance of circulating fibrin monomer.
    Dardik BN; Shainoff JR
    Blood; 1985 Mar; 65(3):680-8. PubMed ID: 3971045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases.
    Mombelli G; Monotti R; Haeberli A; Straub PW
    Thromb Haemost; 1987 Aug; 58(2):758-63. PubMed ID: 3672428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinopeptide A (FPA) level and fibrinogen kinetics in patients with malignant disease.
    Yoda Y; Abe T
    Thromb Haemost; 1981 Dec; 46(4):706-9. PubMed ID: 7330820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinogen survival and fibrinopeptide A in acute leukemia.
    Castaman G; Galloni E; Dri AV; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):52-6. PubMed ID: 8039760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed release of an abnormal fibrinopeptide A from fibrinogen Manchester: effect of the A alpha 16 Arg leads to His substitution upon fibrin monomer polymerization and the immunological crossreactivity of the peptide.
    Lane DA; Southan C; Ireland H; Thompson E; Kehl M; Henschen A
    Br J Haematol; 1983 Apr; 53(4):587-97. PubMed ID: 6830702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High fibrinopeptide A (FPA) levels in acute non-lymphocytic leukemia are reduced by heparin administration.
    Gugliotta L; Viganò S; D'Angelo A; Guarini A; Tura S; Mannucci PM
    Thromb Haemost; 1984 Dec; 52(3):301-4. PubMed ID: 6531754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin abolishes the chemotherapy-induced increase in plasma fibrinopeptide A levels.
    Edwards RL; Klaus M; Matthews E; McCullen C; Bona RD; Rickles FR
    Am J Med; 1990 Jul; 89(1):25-8. PubMed ID: 2368789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fibrinogen metabolism and plasma fibrinopeptide A in disseminated neoplasms].
    Mombelli G; Roux A; Hofmann V; Straub PW
    Schweiz Med Wochenschr; 1979 Dec; 109(47):1901. PubMed ID: 531571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence of release of fibrinopeptide A from fibrinogen molecules by thrombin or Atroxin.
    Meh DA; Siebenlist KR; Bergtrom G; Mosesson MW
    J Lab Clin Med; 1995 Mar; 125(3):384-91. PubMed ID: 7897305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinopeptide A in plasma of normal subjects and patients with disseminated intravascular coagulation and systemic lupus erythematosus.
    Cronlund M; Hardin J; Burton J; Lee L; Haber E; Bloch KJ
    J Clin Invest; 1976 Jul; 58(1):142-51. PubMed ID: 932202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A thrombin assay based upon the release of fibrinopeptide A from fibrinogen: definition of a new thrombin unit.
    Lewis SD; Shafer JA
    Thromb Res; 1984 Jul; 35(2):111-20. PubMed ID: 6474412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between elevated fibrinopeptide A levels and alpha-2-antiplasmin.
    Marongiu F; Mulas G; Mamusa AM; Mameli G; Marassi PP; Tronci MB; Cambuli AB; Acca MR; Balestrieri AA
    Haemostasis; 1987; 17(5):301-4. PubMed ID: 3666588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinopeptide A (FPA) levels in atrial fibrillation and the effects of heparin administration.
    Uno M; Tsuji H; Sawada S; Toyoda T; Nakagawa M
    Jpn Circ J; 1988 Jan; 52(1):9-12. PubMed ID: 3361696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An in vitro evaluation of the hemostatic activity of topical agents.
    Eloy R; Baguet J; Christé G; Rissoan MC; Paul J; Belleville J
    J Biomed Mater Res; 1988 Feb; 22(2):149-57. PubMed ID: 3356713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.